ALNYLAM PHARMACEUTICALS

Lobbying client · Massachusetts · filed 2025 to 2025

Biopharmaceutical company

$140,000 Reported spend

3 Filings counted

1 Firms hired

1 Bills named

Spend is reported income plus in-house expenses across 3 filings. Everything on this page is grouped by the client's LDA id (176479), not by name.

Firms hired 1

THE MCMANUS GROUP $140,000 3 filings

Bills named in these filings 1

HR 1672
Maintaining Investments in New Innovation Act

3 filings

Reported by year 1 year

2025 $140,000 3 filings

Issues lobbied 1

Medicare/Medicaid 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 3
SENATE 3

Recent filings 3 total

3T

THE MCMANUS GROUP

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $20,000 income · posted Oct 20, 2025

View → Q2

THE MCMANUS GROUP

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $60,000 income · posted Jul 21, 2025

View → Q1

THE MCMANUS GROUP

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $60,000 income · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.